NFE2L2 and colorectal carcinoma: Thus, we hypothesized that Ibrutinib inhibited BTK, which prevented Nrf2 translocating to cell nucleus and the activation of the Nrf2 dependent antioxidant genes during oxidative stress conditions and eventually enhanced the sensitivity of CRC cells to ferroptosis.